Srini Tenjarla, PhD.

Dr. Tenjarla is responsible for implementing / overseeing the CMC activities across Serina’s current and future pipeline assets. Srini joined Serina from Takeda Pharmaceuticals, where he served as Vice President and Head of Drug Product Development and Process Chemistry Development/Outsourcing in Pharmaceutical Sciences. In this role, he oversaw phase-appropriate development from Phase 1 through product validation and pre-approval inspection readiness. Prior to his tenure at Takeda, Dr. Tenjarla held several leadership roles at Shire Pharmaceuticals, culminating in his position as Vice President of Pharmaceutical Sciences. Srini holds a Ph.D. in Pharmaceutical Sciences from the University of Houston and a Bachelor of Science in Pharmacy from Andhra University.